In vitro model of human subcutaneous adipocyte spheroids for studying mitochondrial dysfunction and mitochondria activating compounds

Anita Wagner, Juulia Lautaoja-Kivipelto, Kari P. Pehkonen, Antti Hassinen, Minna Kuusela, Luisa S. Röttger, Elena Herbers, Anna Ioannidou, Sophia C. Mädler, Ina Rothenaigner, Sathya Srinivasan, S Laasonen, Mohammad Tariqur Rahman, Pinja Elomaa, S Kortetjärvi, Anna Olsson, Olavi Ukkola, Kamyar Hadian, Matthias Mann, Hilkka Peltoniemi, Kirsi H. Pietiläinen, Martin Klingenspor, Ka Virtanen, Carolina E. Hagberg, Eija PirinenbioRxiv 2025 · DOI

TL;DR

This paper introduces a novel 3D in vitro model using human adipocyte spheroids to study mitochondrial function in obesity. This model successfully mimics key aspects of adipocyte differentiation and lipid overload-induced dysfunction, offering a valuable platform for investigating mitochondrial health and testing potential therapeutic compounds.

What Problem Does This Paper Address?

Obesity is strongly linked to mitochondrial dysfunction in white adipose tissue (WAT), contributing to metabolic complications. However, studying human adipocyte mitochondria in vitro has been challenging due to a lack of physiologically relevant models. Current 2D cell cultures often fail to fully replicate the complex behavior of mature adipocytes, sometimes exhibiting characteristics of brown adipocytes. This gap hinders our understanding of the molecular mechanisms underlying obesity-related mitochondrial dysfunction and the development of effective drug therapies.

Methods

The researchers developed a 3D in vitro model by differentiating human preadipocytes into adipocyte spheroids. Key methodological aspects include:

  • 3D Spheroid Culture: Preadipocytes were cultured in ultra-low attachment plates to form spheroids, mimicking a more in vivo-like environment.
  • Chemically Defined Media: Differentiation was induced using serum-free, chemically defined media to avoid confounding factors and ensure reproducibility.
  • GFR-Matrigel Embedding: For optimal results, spheroids were embedded in Growth Factor Reduced (GFR)-Matrigel, an extracellular matrix component, which improved mitochondrial network and respiration.
  • Lipid Mixture (LM) Administration: To mimic nutrient overload associated with obesity, a lipid mixture was added to the culture media, inducing lipid accumulation and metabolic disturbances.
  • Mitochondrial Respiration Assays: Seahorse XFe96 Analyzer was used to precisely measure various parameters of mitochondrial respiration (basal, ATP-linked, maximal, etc.).
  • Live Cell Imaging: Fluorescence microscopy (BODIPY for lipid droplets, Hoechst for nuclei, MitoTracker for mitochondria) was employed to visualize and quantify cellular and mitochondrial features.
  • Gene Expression Analysis: RT-qPCR was used to assess the expression of key adipogenic and mitochondrial genes.
  • Protein Analysis: Capillary Western blot (JESS system) was used to analyze protein levels, particularly for insulin signaling pathways.
  • Lipolysis Assays: Glycerol release was measured to assess lipolytic activity.

Datasets

The study utilized human subcutaneous adipose tissue samples and preadipocytes from healthy female donors. Specific details on the number of donors and their characteristics (BMI, age) are provided in Table 1. No new benchmark datasets were introduced; rather, the study focused on developing and validating a novel in vitro model.

Key Insights and Ideas

  • 3D Spheroids Mimic In Vivo Adipocytes: The developed adipocyte spheroid model successfully recapitulates key morphological, transcriptional, and metabolic features of in vivo subcutaneous white adipocytes, including lipid accumulation, adipogenic gene expression, and responsiveness to hormonal stimuli.
  • Lipid Overload Induces Mitochondrial Dysfunction: The in vitro model effectively mimics obesity-related metabolic complications by using a lipid mixture to induce significant lipid accumulation and, crucially, mitochondrial dysfunction, characterized by impaired respiration and increased biogenesis.
  • Mitochondrial Changes During Differentiation: Adipocyte differentiation itself leads to significant changes in mitochondrial respiration and biogenesis, shifting towards a more oxidative profile, though with some evidence of reduced efficiency as cells mature.
  • Rosiglitazone as a Potential Therapeutic: The study demonstrates that rosiglitazone, an anti-diabetic drug, can partially reverse LM-induced mitochondrial dysfunction, improve adiponectin secretion, and influence lipid droplet morphology, highlighting its potential as a therapeutic agent.

Key Results

  • Differentiation Efficiency: The adipocyte spheroid model achieved a high differentiation efficiency of nearly 80%, significantly higher than typical monolayer cultures.
  • Mitochondrial Respiration: Differentiated adipocyte spheroids showed significantly elevated basal, ATP-linked, and maximal respiration compared to undifferentiated cells. However, coupling efficiency was reduced, suggesting less efficient mitochondrial respiration.
  • Lipid Accumulation: LM administration significantly increased intracellular triglyceride content and lipid droplet size and number in the spheroids.
  • Adiponectin Secretion: LM administration reduced adiponectin secretion, while rosiglitazone treatment restored it.
  • Insulin Signaling: Insulin stimulation significantly increased p-AktSer473 phosphorylation in differentiated spheroids, but LM administration impaired this response, which was not fully rescued by rosiglitazone.
  • Rosiglitazone Effects: Rosiglitazone treatment increased PPARγ transcriptional activity, improved mitochondrial respiration (ATP-linked, maximal, spare capacity), and restored adiponectin secretion.

Limitations and Future Work

  • Donor Variability: The study used preadipocytes from only two donors, limiting the generalizability of findings. Future work should investigate the influence of donor characteristics (BMI, sex, age, metabolic diseases) on differentiation and function.
  • Absence of Other Cell Types: The model solely uses preadipocytes, lacking other cell types present in scWAT (e.g., endothelial cells, immune cells). This absence might influence lipid droplet morphology and metabolic profiles, and future models could incorporate these cell types.
  • GFR-Matrigel: While beneficial, GFR-Matrigel is an animal-derived component that could introduce non-physiological signals. Its uneven incorporation also leads to experimental variation, suggesting a need for high replication.
  • Imaging Limitations: Current live cell imaging techniques only capture the outer layer of spheroids. Cryosectioning confirmed adipocytes in the core, but further development in imaging could provide a more complete picture.
  • Insulin-Sensitizing Effects: The study did not observe a clear insulin-sensitizing effect of rosiglitazone via Akt phosphorylation, suggesting this mechanism might operate independently and warrants further investigation.

Future work could focus on exploring the role of other cell types in the scWAT microenvironment, investigating the impact of various donor characteristics, and further elucidating the mechanisms behind rosiglitazone's insulin-sensitizing effects. The model also holds promise for assessing potential mitochondrial toxicity of drugs.

Summary updated

Abstract

SUMMARY Mitochondrial abnormalities drive subcutaneous white adipose tissue dysfunction in obesity, leading to metabolic complications. A key challenge in obesity research is the lack of in vitro models to study human adipocyte mitochondria. Here, we establish a human subcutaneous adipocyte spheroid model to characterize mitochondrial metabolism under obesity-relevant conditions and drug exposure. Human preadipocyte spheroids were differentiated in ultra-low attachment plates for 3 weeks in media free of thiazolidinediones. The differentiated adipocyte spheroids showed increased lipid accumulation, adipogenic gene expression, mitochondrial respiration and adiponectin secretion, and a proper response to hormonal stimulation. Lipid mixture administration during differentiation induced metabolic disturbances including mitochondrial respiration failure associated with increased mitochondrial biogenesis. Post-differentiation treatment with rosiglitazone, a peroxisome proliferator-activated receptor γ agonist, improved mitochondrial bioenergetics and adiponectin secretion in lipid mixture-administered adipocyte spheroids. Our model enables precise measurement of adipocyte mitochondria under various conditions, providing a platform for mitochondria-related research and drug discovery in obesity.
BibTeX
@misc{wagner2025i,
  author = {Anita Wagner and Juulia Lautaoja-Kivipelto and Kari P. Pehkonen and Antti Hassinen and Minna Kuusela and Luisa S. Röttger and Elena Herbers and Anna Ioannidou and Sophia C. Mädler and Ina Rothenaigner and Sathya Srinivasan and S Laasonen and Mohammad Tariqur Rahman and Pinja Elomaa and S Kortetjärvi and Anna Olsson and Olavi Ukkola and Kamyar Hadian and Matthias Mann and Hilkka Peltoniemi and Kirsi H. Pietiläinen and Martin Klingenspor and KA Virtanen and Carolina E. Hagberg and Eija Pirinen},
  title = {{<i>In vitro</i> model of human subcutaneous adipocyte spheroids for studying mitochondrial dysfunction and mitochondria activating compounds}},
  year = {2025},
  doi = {10.1101/2025.04.16.649074},
  howpublished = {bioRxiv},
}
Figure